  | Advertisements: |
Hot themes this week:
|
| » Read discussion on Eli Lilly
07/13/11 The Zacks Analyst Blog Highlights: Alkermes, Amylin Pharmaceuticals, Eli Lilly and Company, Liberty Property Trust and Duke Realty
07/11/11 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced results from a thorough QT (tQT) study that assessed the potential of exenatide to increase the QT interval across a wide range of plasma concentrations.
07/08/11 Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced results from a thorough QT (tQT) study that assessed the potential of exenatide to increase the QT interval across a wide range of plasma concentrations.
06/24/11 SAN DIEGO, June 24, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced additional results from a phase 2 study of an investigational, once-monthly injectable suspension formulation of exenatide which showed substantial improvements in glycemic control, including reductions in A1C and fasting plasma ...
06/23/11 NEW YORK--(BUSINESS WIRE)--Greene Concepts, Inc. (Pink Sheets: LKEN) - Greene Concepts is pleased to announce the welcoming of another savvy and creative business person to the Executive Board of Directors Mark Aguilar. Mr. Aguilar has served as a Specialty Sales and Marketing Associate for Eli Lilly and Company since 2007 (Eli Lilly was founded in 1876 and is now the 10th largest pharmaceutical ...
06/20/11 RIDGEFIELD, Conn. and INDIANAPOLIS, June 20, 2011 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) will present the latest data from their diabetes portfolio at the 71st American Diabetes Association (ADA) Scientific Sessions in San Diego on June 24-28. Study results evaluating the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, as well as the investigational ...
06/16/11 On the Move Name: Dr. David M. Kendall. New post: Distinguished fellow and senior medical advisor for diabetes by Eli Lilly and Co. Previous position: Chief scientific and medical officer at the American Diabetes Association.
06/15/11 Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Tradjenta?? tablets are now available by prescription in pharmacies across the United States including Walgreens, CVS, Rite Aid and many leading chain and independent pharmacies.
06/15/11 RIDGEFIELD, Conn. and INDIANAPOLIS, June 15, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced Tradjenta(TM) (linagliptin) tablets are now available by prescription in pharmacies across the United States including Walgreens, CVS, Rite Aid and many leading chain and independent pharmacies. The U.S. Food and Drug Administration ...
06/14/11 Charles Byron Landis, M.D., 83, passed away peacefully in his home in Venice, FL, on June 4, 2011, after several months of declining health. Dr. Landis had resided with his wife of nearly 60 years, Marqueta Davis, who survives, for the past 19 years in Englewood, FL. Prior to his retirement, Dr. Landis was an Occupational Physician with Eli Lilly, Tippecanoe Labs for 20 years and an ...
05/18/11 Eli Lilly and Company today announced that David M. Kendall, M.D., currently chief scientific and medical officer of the American Diabetes Association, has been named distinguished medical fellow for Lilly.
05/12/11 Eli Lilly and Co.'s Amyvid, an imaging agent to detect signs of Alzheimer's disease in the brain, shouldn't be approved because of unreliable study results, a consumer-advocacy group said.
05/09/11 Fairholme Focused Income Fund buys heavily into telephone companies and pharmaceuticals to generate yield for the fund. It bought into Telefonica S.a., Astrazeneca Plc, Glaxosmithkline Plc, Bristolmyers Squibb Co., Eli Lilly & Co., At&T Inc., sells General Growth Properties Inc., Mercury General Corp. during the 3-months ended 02/28/2011, according to the most recent filings of his investment ...
05/08/11 From Italy to Indy -- not exactly a cheap move. But Filippo Fontana didn't spend a dime. "The company, they're covering all the expenses," said Fontana, who was relocated to Indianapolis for a job with drug maker Eli Lilly and Co. in February.
05/08/11 Eli Lilly relocated employee Filippo Fontana, shown with wife Rosana and son Luca, to Indianapolis from Italy in February. An Atlas Van Lines survey finds 30 percent of companies expect to relocate workers this year. That level, the highest in six years, is a sign of a strengthening economy.
05/04/11 Hear From Government and Business Leaders from U.S. Sentencing Commission, Dow Jones, Microsoft, Bechtel, TAMKO, Philip Morris, Eli Lilly, World Bank Group, Department of Homeland Security, Boeing, U.S. Department of Justice, FBL Financial Group, British Telecom, Starbucks, Walmart, and many more
04/18/11 Quarterly reports on deck for Eli Lilly, Gannett, KeyCorp, Texas Instruments and Citigroup as U.S. earnings season shifts into high gear.
04/17/11 Quarterly reports on deck from Eli Lilly, Gannett, Keycorp, TI, Halliburton and Citi as U.S. earnings season shifts into a high gear.
04/01/11 INDIANAPOLIS, April 1, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that AxironŽ (testosterone) topical solution is available in pharmacies throughout the United States. Axiron is a prescription medicine used to treat adult males that have low or no testosterone. Safety and efficacy of Axiron in males younger than 18 years of age have not been established. The U.S. Food ...
03/31/11 Eli Lilly and Company's new global service program, Connecting Hearts Abroad, is set to launch. Through the program, the company is sending 200 Lilly Ambassadors to assist people and communities that often lack basic resources.
03/15/11 Rolls-Royce is moving about 2,500 workers to an office complex that was formerly used by Eli Lilly, officials say. |
